Modulation of TNF-α-induced apoptosis in corneal fibroblasts by transcription factor NF-κB

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1327-1336

  Mohan, Rajiv R ^a,b   Mohan, Rahul R ^a,b   Kim, Woo Jung ^b,c   Wilson, Steven E ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORTICOSTEROID; DACTINOMYCIN; DEXAMETHASONE; DICLOFENAC; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETOROLAC TROMETAMOL; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CHILD; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFANT; PRIORITY JOURNAL;

ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELLS, CULTURED; CHILD, PRESCHOOL; CORNEA; DNA; DNA PRIMERS; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034013078     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. DeLong MJ. Apoptosis: a modulator of cellular hemostasis and disease states. Ann NY Acad Sci. 1998;842:82-90.
2. Vaux DL, Hacker G, Strasser A. An evolutionary perspective on apoptosis. Cell. 1994;76:777-779.
3. Kokawa K, Shikone T, Nakano R. Apoptosis in human chorionic and decidua during normal embryonic development and spontaneous abortion in first trimester. Placenta. 1998;19:21-26.
4. Cohen JJ. Programmed cell death in the immune system. Adv Immunol. 1991;50:55-85.
5. Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS. 1994;8:1197-1213.
6. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer. 1994;73:2013-2026.
7. Lane SC, Jolly JD, Schmechel DE, Alroy J, Boustany RM. Apoptosis as the mechanism of neurodegeneration in Batten's disease. J Neurochem. 1996;67:677-683.
8. Wilson SE, Pedroza L, Beuerman R, Hill JM. Herpes simplex virus type-1 infection of corneal epithelial cells induces apoptosis of the underlying keratocytes. Exp Eye Res. 1997;64:775-779.
9. Wilson SE, He Y-G, Weng J, Li Q, Vital M, Chwang EL. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization. Exp Eye Res. 1996;62:325-338.
10. Helena MC, Baerveldt F, Kim W-J, Wilson SE. Keratocyte apoptosis following corneal surgery. Invest Ophthalmol Vis Sci. 1998;39: 276-283.
11. Kim W-J, Rabinowitz YS, Meisler DM, Wilson SE. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69:475-481.
12. Wilson SE, Kim W-J. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
13. Wilson SE, Li Q, Weng J, et al. The Fas/Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci. 1996;37:1582-1592.
14. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
15. Mohan RR, Liang Q, Kim W-J, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res. 1997;65:575-589.
16. Mohan, RR, Kim W-J, Mohan RR, Chen L, Wilson SE. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci. 1998;39:2626-2636.
17. Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ, Shepard HM. Modulation of transformed cells by human tumor necrosis factor α and Interferon gamma. Cancer Res. 1987;47:5382-5385.
18. Vilcek J, Tsujimoto M, Palombella VJ, Kohase M, Le J. Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts. J Cell Physiol. 1987;5(suppl):57-61.
19. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor α (TNFα) induced optic neuropathy in rabbits. Neurol Res 1996;18:176-184.
20. Agostini C, Zambello R, Trentin L, et al. Expression of receptors by T cells and membrane TNF-α by alveolar macrophages suggests a role for TNF-α in the regulation of the local immune responses in the lung of HIV-1-infected patients. J Immunol. 1995;154:2928-2938.
21. Klein SA, Dobmeyer JM, Dobmayer TS, et al. TNF-α mediated apoptosis of CD4 positive T-lymphocytes: a model of T-cell depletion in HIV infected individuals. Eur J Med Res. 1996;1:249-258.
22. Prins JB, Neisler CU, Winterford CM, et al. Tumor necrosis factor α induces apoptosis of human adipose cells. Diabetes. 1997;46: 1939-1944.
23. Hobden JA, Masinick SA, Barrett RP, Hazlett LD. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun. 1997;65: 2754-2758.
24. Kennedy M, Kim KH, Harten B, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci. 1997;38:2483-2491.
25. Lausch RN, Chen SH, Tumpey TM, Su YH, Oakes JE. Early cytokine synthesis in the excised mouse cornea. J Interferon Cytokine Res. 1996;16:35-40.
26. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines, and disease. Annu Rev Cell Biol. 1993;9:317-343.
27. Carswell EA, Old LJ, Kassel RA, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666-3670.
28. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death. Science. 1996;274:782-784.
29. Holtmann H, Hahn T, Wallach D. Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. Immunobiology. 1988;177:7-22.
30. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 1997;385:540-544.
31. Wang C-Y, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 1996;274:784-787.
32. Antwerp DJV, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α induced apoptosis by NF-κB. Science. 1996;274: 787-789.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
34. Leonardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue specific gene control. Cell. 1989;58:227-229.
35. Smith CA, Farrah T, Goodwin RG. The TNF-receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994;76:959-962.
36. Vandenabelle P, Declercg W, Bayaert R, Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 1995;5:392-399.
37. Liu Z, Hsu H, Goeddel DV, Karin M. Dissection of TNF-receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 1996;97:565-576.
38. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res. 1998;67:619-624.
39. Sunderkotter C, Roth J, Sorg C. Immunohistochemical detection of bFGF and TNF-α in the course of inflammatory angiogenesis in the mouse cornea. AmJ Pathol. 1990;137:511-515.
40. Molossi S, Clausell N, Rabinovitch M. Reciprocal induction of tumor necrosis factor-α and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J Cell Physiol. 1995;163:19-29.
41. Oxholm A. Epidermal expression of interleukin-6 and tumour necrosis factor-α in normal and immunoinflammatory skin states in humans. APMIS Suppl. 1992;24:1-32.
42. Ahmed AA, Nordind K, Schultzberg M, Linden S. Immunohistochemical localization of IL-1 a, IL-1 beta, IL-6, and TNF-α-like immunoreactivities in human apocrine glands. Arch Dermatol Res. 1995;287:764-766.
43. Grilli M, Chiu JJ-S, Lenardo MJ. NF-κB and Rel-participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993; 143:1-62.
44. Baldwin AS. Transcription. In: Conaway RC, Canaway JW, eds. Mechanisms and Regulation. New York: Raven; 1994;443-457.
45. Baeuerle PA, Henkel T. Function and activation of NF-κB in immune system. Annu Rev Immunol. 1994;12:141-179.
46. Beg A, Sha W, Bronson R, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature. 1995;376:167-170.
47. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor kappa B. Proc Natl Acad Sci, USA. 1989;86:2336-2340.
48. Baeuerle PA. The inducible transcription factor NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072: 63-80.
49. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 1994;265:956-961.
50. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283-286.
51. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis Science. 1995;270: 286-290.
52. Gartry DS, Muir MG, Lohmann CP, Marshall J. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. A prospective, randomized, double-blind trial. Arch Ophthalmol. 1992;110:944-952.
53. Shimoyama M, Shimmura S, Tsubota K, Oguchi Y. Suppression of nuclear factor kappa B and CD18-mediated leukocyte adhesion to the corneal endothelium by dexamethasone. Invest Ophthalmol Vis Sci. 1997;38:2427-31.